Literature DB >> 21846428

Significant inverse associations of serum n-6 fatty acids with plasma plasminogen activator inhibitor-1.

Sunghee Lee1, J David Curb, Takashi Kadowaki, Rhobert W Evans, Katsuyuki Miura, Tomoko Takamiya, Chol Shin, Aiman El-Saed, Jina Choo, Akira Fujiyoshi, Teruo Otake, Sayaka Kadowaki, Todd Seto, Kamal Masaki, Daniel Edmundowicz, Hirotsugu Ueshima, Lewis H Kuller, Akira Sekikawa.   

Abstract

Epidemiological studies suggested that n-6 fatty acids, especially linoleic acid (LA), have beneficial effects on CHD, whereas some in vitro studies have suggested that n-6 fatty acids, specifically arachidonic acid (AA), may have harmful effects. We examined the association of serum n-6 fatty acids with plasminogen activator inhibitor-1 (PAI-1). A population-based cross-sectional study recruited 926 randomly selected men aged 40-49 years without CVD during 2002-2006 (310 Caucasian, 313 Japanese and 303 Japanese-American men). Plasma PAI-1 was analysed in free form, both active and latent. Serum fatty acids were measured with gas-capillary liquid chromatography. To examine the association between total n-6 fatty acids (including LA and AA) and PAI-1, multivariate regression models were used. After adjusting for confounders, total n-6 fatty acids, LA and AA, were inversely and significantly associated with PAI-1 levels. These associations were consistent across three populations. Among 915 middle-aged men, serum n-6 fatty acids had significant inverse associations with PAI-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846428      PMCID: PMC3236804          DOI: 10.1017/S0007114511003199

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  35 in total

1.  Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; N Aleksic; E Park; V Salomaa; H Juneja; K K Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

Review 2.  Plasminogen-activator inhibitor type 1 and coronary artery disease.

Authors:  H P Kohler; P J Grant
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

3.  Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention.

Authors:  William S Harris; Dariush Mozaffarian; Eric Rimm; Penny Kris-Etherton; Lawrence L Rudel; Lawrence J Appel; Marguerite M Engler; Mary B Engler; Frank Sacks
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

4.  Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study.

Authors:  Jina Choo; Hirotsugu Ueshima; J David Curb; Chol Shin; Rhobert W Evans; Aiman El-Saed; Takashi Kadowaki; Tomonori Okamura; Katsumi Nakata; Teruo Otake; Katsuyuki Miura; Robert D Abbott; Kim Sutton-Tyrrell; Daniel Edmundowicz; Lewis H Kuller; Akira Sekikawa
Journal:  Am J Clin Nutr       Date:  2010-03-31       Impact factor: 7.045

5.  The alteration of plasminogen activator inhibitor-1 expression by linoleic acid and fenofibrate in HepG2 cells.

Authors:  Ping Ye; Yan-Li He; Qiong Wang; Yong-Xue Liu
Journal:  Blood Coagul Fibrinolysis       Date:  2007-01       Impact factor: 1.276

Review 6.  Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.

Authors:  Philip C Calder
Journal:  Biochimie       Date:  2009-06       Impact factor: 4.079

7.  Coronary artery calcification in Japanese men in Japan and Hawaii.

Authors:  Robert D Abbott; Hirotsugu Ueshima; Beatriz L Rodriguez; Takashi Kadowaki; Kamal H Masaki; Bradley J Willcox; Akira Sekikawa; Lewis H Kuller; Daniel Edmundowicz; Chol Shin; Atsunori Kashiwagi; Yasuyuki Nakamura; Aiman El-Saed; Tomonori Okamura; Roger White; J David Curb
Journal:  Am J Epidemiol       Date:  2007-08-28       Impact factor: 4.897

Review 8.  The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases.

Authors:  Hunjoo Ha; Eun Y Oh; Hi B Lee
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

Review 9.  The opposing effects of n-3 and n-6 fatty acids.

Authors:  Gerd Schmitz; Josef Ecker
Journal:  Prog Lipid Res       Date:  2007-12-25       Impact factor: 16.195

10.  Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension.

Authors:  Wen-Sheng Zhao; Jia-Jie Zhai; Yi-Hui Wang; Pa-Sha Xie; Xiao-Jing Yin; Long-Xue Li; Kang-Lin Cheng
Journal:  Am J Hypertens       Date:  2009-03-19       Impact factor: 2.689

View more
  3 in total

Review 1.  Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention.

Authors:  Akira Sekikawa; J David Curb; Daniel Edmundowicz; Tomonori Okamura; Jina Choo; Akira Fujiyoshi; Kamal Masaki; Katsuyuki Miura; Lewis H Kuller; Chol Shin; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2012-04-07       Impact factor: 3.211

2.  Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults.

Authors:  Salma A Abdelmagid; Shannon E Clarke; Daiva E Nielsen; Alaa Badawi; Ahmed El-Sohemy; David M Mutch; David W L Ma
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

3.  Allele-specific methylation in the FADS genomic region in DNA from human saliva, CD4+ cells, and total leukocytes.

Authors:  Elaheh Rahbar; Charlotte Mae K Waits; Edward H Kirby; Leslie R Miller; Hannah C Ainsworth; Tao Cui; Susan Sergeant; Timothy D Howard; Carl D Langefeld; Floyd H Chilton
Journal:  Clin Epigenetics       Date:  2018-04-06       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.